A detailed history of Formula Growth LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Formula Growth LTD holds 2,663 shares of LLY stock, worth $1.92 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
2,663
Holding current value
$1.92 Million
% of portfolio
0.97%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$725.72 - $929.72 $1.93 Million - $2.48 Million
2,663 New
2,663 $2.2 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $684B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Formula Growth LTD Portfolio

Follow Formula Growth LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formula Growth LTD, based on Form 13F filings with the SEC.

News

Stay updated on Formula Growth LTD with notifications on news.